Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Cerebral glucose utilization and blood flow in Huntington's Disease (HD)

Conference · · J. Nucl. Med.; (United States)
OSTI ID:6791601
Previous studies in the authors' Laboratory have been carried out on 13 patients symptomatic of HD (SHD) and 15 asymptomatic at-risk for HD (ARHD) with a ECAT II and identification of changes in caudate metabolism using an index technique. The authors report now studies of additional 28 subjects (11 SHD, 17 ARHD) studied drug free and compared to age/sex matched controls using the higher resolution NeuroECAT, FDG for glucose utilization (LCMRGlc) and 0-15 water for cerebral blood flow (CBF). Patients had neurological, psychiatric-tests, x-ray CT and were video taped to determine type, timing and amount of choreathetic movements during study. In SHD (disease duration 4.9 +- 2.7 yrs), significant decreases (30%) in LCMRGlc were found in striatum (SHD=19.3 +- 7.7, controls = 29.9 +- 5.8 ..mu.. moles/min/100g) despite no to moderate caudate atrophy on x-ray CT. Hemisphere and cortical CMRGlc were not significantly decreased. There was a significant correlation between disease duration and ratio of caudate to putamen (Cd/Put). Pattern of LCMRGlc and CBF matched in SHD. The caudate to hemisphere LCMRGlc ratio was not different between ARHD and controls except variance was about 4 times greater for ARHD (ARHD=1.21 +- 0.15, controls = 1.28 +- 0.04) indicating presence of subpopulations in ARHD group. Four ARHD subjects had a ratio of 1 Std. Dev. from mean of SHD (no normals had values in this range). The 2 ARHD subjects with lowest caudate LCMRGlc had Cd/Put ratios > 2 Std. Dev. from controls. Results show 1) LCMRGlc abnormalities in all SHD patients and subpopulations in ARHD, 2) metabolic alterations appear to begin in caudate and spread to putamen and that a Cd/Put value of 0.7 should be found at start of symptoms, and 3) cortex and thalamus are relatively spared in ARHD and early SHD.
Research Organization:
UCLA School of Medicine, Los Angeles, CA
OSTI ID:
6791601
Report Number(s):
CONF-850611-
Conference Information:
Journal Name: J. Nucl. Med.; (United States) Journal Volume: 26:5
Country of Publication:
United States
Language:
English